Dr. Amy D. Tiersten
Claim this profileIcahn School of Medicine at Mount Sinai
Studies Breast Cancer
Studies Metastasis
8 reported clinical trials
17 drugs studied
Area of expertise
1Breast Cancer
Stage IV
ER positive
HER2 positive
2Metastasis
Stage IV
AR positive
Stage III
Affiliated Hospitals
Clinical Trials Amy D. Tiersten is currently running
Lasofoxifene and Abemaciclib vs Fulvestrant and Abemaciclib
for Breast Cancer
The goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for the treatment of pre- and postmenopausal women and men who have previously received ribociclib or palbociclib-based treatment and have locally advanced or metastatic estrogen receptor positive (ER+)/human epidermal growth factor 2 negative (HER2-) breast cancer with an estrogen receptor 1 (ESR1) mutation. The main question the study aims to answer is: • To compare the efficacy of the combination of lasofoxifene and abemaciclib with that of fulvestrant and abemaciclib Participants will receive either receive 5 mg/d of oral lasofoxifene plus oral abemaciclib 150 mg twice a day or the combination of fulvestrant 500 mg intramuscular (IM) on Days 1, 15, and 29 and then once monthly thereafter plus oral abemaciclib 150 mg twice a day.
Recruiting2 awards Phase 312 criteria
Abemaciclib + Bicalutamide
for Breast Cancer
This is an open label multicenter, Phase IB/II Study of Abemaciclib in Combination with Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
Recruiting3 awards Phase 1 & 218 criteria
More about Amy D. Tiersten
Clinical Trial Related1 year of experience running clinical trials · Led 8 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Amy D. Tiersten has experience with
- Abemaciclib
- Lasofoxifene
- Fulvestrant
- Bicalutamide
- Sacituzumab
- Cisplatin
Breakdown of trials Amy D. Tiersten has run
Breast Cancer
Endometrial Cancer
Uterine Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Amy D. Tiersten specialize in?
Amy D. Tiersten focuses on Breast Cancer and Metastasis. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are ER positive.
Is Amy D. Tiersten currently recruiting for clinical trials?
Yes, Amy D. Tiersten is currently recruiting for 5 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Amy D. Tiersten has studied deeply?
Yes, Amy D. Tiersten has studied treatments such as Abemaciclib, Lasofoxifene, Fulvestrant.
What is the best way to schedule an appointment with Amy D. Tiersten?
Apply for one of the trials that Amy D. Tiersten is conducting.
What is the office address of Amy D. Tiersten?
The office of Amy D. Tiersten is located at: Icahn School of Medicine at Mount Sinai, New York, New York 10029 United States. This is the address for their practice at the Icahn School of Medicine at Mount Sinai.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.